Strategies to Improve the Diagnosis and Management of Migraine in Primary Care: A Focus on CGRP-Targeted Agents for the Acute Treatment and Prevention of Episodic Migraine

Dates
  • Thursday, December 5, 2024
  • Thursday, December 12, 2024
  • Thursday, December 19, 2024
 
Time
1:00 PM (UTC-05:00) Eastern Time (US & Canada)
 
Duration
60 minutes
 
Credit Type
CME,CNE,AAPA, AANP
 
Intended Learners

This activity is intended for primary care clinicians, including physicians, NPs, PAs, residents, fellows, RNs, and other members of the primary care team, as well as and other relevant physician specialties who may play a role in the management of migraine.

 
Learning Objectives
  1. Describe current unmet needs related to the diagnosis and management of migraine in primary care practice 
  2. Evaluate the role of CGRP in the pathophysiology of migraine 
  3. Assess the safety/efficacy data of CGRP receptor antagonists in the acute treatment of migraine and the preventive treatment of episodic migraine 
  4. Implement personalized care plans which consider healthcare disparities and comorbidities for the optimal management of patients with migraine
 
Continuing Education
 
Jointly Accredited Provider
 

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Note: This statement is not an indication of approved credits. Check back soon for full accreditation information.

Supported by an independent educational grant from Pfizer Inc.

 

Speakers

James North, MD
Albany Medical College
Diplomate, ABFM, Assistant Clinical Professor
Anne Damian Yacoub, MD
Johns Hopkins School of Medicine
Co-Director, Johns Hopkins Headache Center, Assistant Professor, Department of Neurology